{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,8]],"date-time":"2025-05-08T13:32:38Z","timestamp":1746711158409,"version":"3.40.5"},"reference-count":14,"publisher":"American Academy of Pediatrics (AAP)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,10,1]]},"abstract":"<jats:title>This Policy Statement was retired January 2015.<\/jats:title>\n               <jats:p>Despite marked progress in global polio eradication, the threat of polio importation into the United States remains; therefore, all children should be protected against the disease. The standard schedule for poliovirus immunization remains 4 doses of inactivated poliovirus vaccine at 2, 4, and 6 through 18 months and 4 through 6 years of age. The minimum interval between doses 1 and 2 and between doses 2 and 3 is 4 weeks, and the minimum interval between doses 3 and 4 is 6 months. The minimum age for dose 1 is 6 weeks. Minimal age and intervals should be used when there is imminent threat of exposure, such as travel to an area in which polio is endemic or epidemic. The final dose in the inactivated poliovirus vaccine series should be administered at 4 through 6 years of age, regardless of the previous number of doses administered before the fourth birthday, and at least 6 months since the last dose was received.<\/jats:p>","DOI":"10.1542\/peds.2011-1751","type":"journal-article","created":{"date-parts":[[2011,9,27]],"date-time":"2011-09-27T03:44:22Z","timestamp":1317095062000},"page":"805-808","source":"Crossref","is-referenced-by-count":4,"title":["Poliovirus"],"prefix":"10.1542","volume":"128","author":[{"name":"Committee on Infectious Diseases","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"417","published-online":{"date-parts":[[2011,10,1]]},"reference":[{"issue":"6","key":"2023092514504279100_B1","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1542\/peds.104.6.1404","article-title":"Prevention of poliomyelitis: recommendations for use of only inactivated poliovirus vaccine for routine immunization","volume":"104","author":"American Academy of Pediatrics, Committee on Infectious Diseases","year":"1999","journal-title":"Pediatrics"},{"issue":"30","key":"2023092514504279100_B2","first-page":"829","article-title":"Updated recommendations of the Advisory Committee on Immunization Practices (ACIP) regarding routine poliovirus vaccination","volume":"58","author":"Centers for Disease Control and Prevention","year":"2009","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"2023092514504279100_B3","doi-asserted-by":"crossref","first-page":"S424","DOI":"10.1093\/clinids\/6.Supplement_2.S424","article-title":"Control of paralytic poliomyelitis in the United States","volume":"6","author":"Schonberger","year":"1984","journal-title":"Rev Infect Dis"},{"issue":"RR-3","key":"2023092514504279100_B4","first-page":"1","article-title":"Poliomyelitis prevention in the United States: introduction of a sequential vaccination schedule of inactivated poliovirus vaccine followed by oral poliovirus vaccine\u2014recommendations of the Advisory Committee on Immunization Practices (ACIP) [published correction appears in MMWR Morb Mortal Wkly Rep. 1997;46(8):183]","volume":"46","author":"Centers for Disease Control and Prevention","year":"1997","journal-title":"MMWR Recomm Rep"},{"issue":"3","key":"2023092514504279100_B5","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1097\/00006454-199703000-00011","article-title":"Fifteen years of experience with Vero-produced enhanced potency inactivated poliovirus vaccine","volume":"16","author":"Vidor","year":"1997","journal-title":"Pediatr Infect Dis J"},{"key":"2023092514504279100_B6","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/B978-1-4160-3611-1.50030-1","article-title":"Poliovirus vaccine\u2014live","volume-title":"Vaccines","author":"Sutter","year":"2008","edition":"5th ed"},{"issue":"23","key":"2023092514504279100_B7","first-page":"213","article-title":"Polio vaccines and polio immunization in the pre-eradication era: WHO position paper","volume":"85","author":"World Health Organization","year":"2010","journal-title":"Wkly Epidemiol Rec"},{"issue":"6","key":"2023092514504279100_B8","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1111\/j.1539-6924.2006.00831.x","article-title":"Retrospective cost-effectiveness analysis for polio vaccination in the United States","volume":"26","author":"Thompson","year":"2006","journal-title":"Risk Anal"},{"issue":"19","key":"2023092514504279100_B9","doi-asserted-by":"crossref","first-page":"1981","DOI":"10.1056\/NEJMsa0806477","article-title":"Vaccine refusal, mandatory immunization and the risk of vaccine-preventable diseases","volume":"360","author":"Omer","year":"2009","journal-title":"N Engl J Med"},{"issue":"3","key":"2023092514504279100_B10","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1086\/596052","article-title":"Transmission of imported vaccine-derived poliovirus in an undervaccinated community in Minnesota","volume":"199","author":"Alexander","year":"2009","journal-title":"J Infect Dis"},{"issue":"1","key":"2023092514504279100_B11","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1086\/508427","article-title":"Serologic response to inactivated polio vaccine: a randomized clinical trial comparing 2 vaccination schedules in Puerto Rico","volume":"195","author":"Dayan","year":"2007","journal-title":"J Infect Dis"},{"issue":"4","key":"2023092514504279100_B12","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1002\/1096-9071(200104)63:4<305::AID-JMV1006>3.0.CO;2-U","article-title":"Age- and dose-interval-dependent antibody responses to inactivated poliovirus vaccine","volume":"63","author":"Sormunen","year":"2001","journal-title":"J Med Virol"},{"issue":"5","key":"2023092514504279100_B13","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/0264-410X(90)90244-G","article-title":"Polio immunity to killed vaccine: an 18-year follow-up","volume":"8","author":"B\u00f6ttiger","year":"1990","journal-title":"Vaccine"},{"issue":"2","key":"2023092514504279100_B14","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.vaccine.2008.10.061","article-title":"Need for polio boosters after age two years","volume":"27","author":"Rennels","year":"2009","journal-title":"Vaccine"}],"container-title":["Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/128\/4\/805\/1531486\/zpe01011000805.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/128\/4\/805\/1531486\/zpe01011000805.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,25]],"date-time":"2023-09-25T14:51:28Z","timestamp":1695653488000},"score":1,"resource":{"primary":{"URL":"https:\/\/publications.aap.org\/pediatrics\/article\/128\/4\/805\/30697\/Poliovirus"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,10,1]]},"references-count":14,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2011,10,1]]},"published-print":{"date-parts":[[2011,10,1]]}},"URL":"https:\/\/doi.org\/10.1542\/peds.2011-1751","relation":{},"ISSN":["0031-4005","1098-4275"],"issn-type":[{"type":"print","value":"0031-4005"},{"type":"electronic","value":"1098-4275"}],"subject":[],"published":{"date-parts":[[2011,10,1]]}}}